3,4 GLP-1RAs mimic the action of endogenous GLP-1, activating GLP-1R, thereby enhancing insulin secretion, inhibiting glucagon release, delaying gastric emptying, and reducing food intake through central appetite suppression
[DOI] [PMC free article] [PubMed] [Google Scholar] 36.Ajibade T.O., Arowolo R., Olayemi F.O
Here is the truth
Their team is clear about limitations, including cost, insurance challenges, and the need for comprehensive treatment models that integrate therapy and long-term support
13 This study found that rats treated with exendin-4 had increased endothelial progenitor cells and protein levels of vascular endothelial growth factor receptor-2 (VEGF R2), phosphorylated endothelial nitric oxide synthase (eNOS), matrix metalloproteinase-2 (MMP-2), and transforming growth factor- (TGF-)
Therefore, expanding the range of available pharmacotherapies is essential to better support individuals with AUD [9]